)
Whitehawk Therapeutics (WHWK) investor relations material
Whitehawk Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 11, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 10, 2026.
Voting matters and shareholder proposals
Election of three Class III directors to serve until the 2029 annual meeting or until successors are qualified.
Advisory vote to approve executive compensation as disclosed in the 2025 Summary Compensation Table.
Ratification of BDO USA, P.C. as independent registered accounting firm for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Nominees for Class III directors are Behzad Aghazadeh, Ph.D., Richard Maroun, and Emma Reeve.
- Annual meeting to vote on directors, executive pay, auditor, and review governance and capital changes.WHWK
Proxy filing28 Apr 2026 - Improved financials and strong cash position support ongoing clinical progress into 2028.WHWK
Q4 202512 Mar 2026 - Three differentiated ADCs progress toward key clinical milestones, with data expected by early 2027.WHWK
The Citizens Life Sciences Conference 202610 Mar 2026 - Three differentiated ADCs advance in parallel, targeting broad cancer indications with strong stability and safety.WHWK
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Advancing three differentiated ADCs with clinical data expected in 2027 and strong cash runway.WHWK
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026 - Next-gen ADCs show superior preclinical results, with clinical data expected in early 2027.WHWK
Jefferies London Healthcare Conference 20253 Feb 2026 - FYARRO sales rose 15% sequentially; cash runway extends into Q4 2025 as trials advance.WHWK
Q2 20242 Feb 2026 - PRECISION1's interim data in Q3 could expand reach beyond PEComa, with pipeline trials progressing.WHWK
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - $100M FYARRO sale, $100M PIPE, and ADC in-licensing drive late 2028 runway and clinical focus.WHWK
Investor Update10 Jan 2026
Next Whitehawk Therapeutics earnings date
Next Whitehawk Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage